Yes, New Jersey employers can still test for cannabis as of October 14, 2026. But the New Jersey Cannabis Regulatory Commission says a test showing cannabinoid metabolites by itself is not enough to support adverse action; the employer also needs documented signs or other evidence of impairment during your work hours.
That distinction matters if you used cannabis legally off the job and now face a workplace test. A positive result can show prior exposure, while the workplace question is whether there is evidence connected to impairment at work.
Can a New Jersey employer act on a positive marijuana test?
As of October 14, 2026, New Jersey employers may maintain a drug-free workplace and may require testing when there is reasonable suspicion of cannabis use while you are working, observable signs of impairment, a random-testing program, or a work-related accident under investigation. The NJ-CRC workplace guidance says a scientifically reliable test for cannabinoid metabolites alone is insufficient for adverse employment action.
In plain words: the test result is one piece of information, not the whole workplace story. The CRC says a result paired with evidence-based documentation of physical signs or other evidence of impairment during prescribed work hours may be enough to support action.
This is why an employer’s written policy and the reason for the test both matter. For a practical explanation of what a positive result does and does not show, see THC drug-test cutoffs. For the testing process itself, screening and MRO review explains the usual terms you may hear.
What should an employer document when it suspects impairment?
As of October 14, 2026, the CRC guidance describes evidence-based protocols for documenting observed behavior and physical signs to establish reasonable suspicion. It includes a sample Reasonable Suspicion Observation Report and says an employer may use its own existing report if it already has one.
The guidance says a workplace process may include:
- A trained staff member or third-party contractor who can help assess suspected impairment.
- A uniform report recording behavior, physical signs, and other observations.
- A manager or supervisor plus the designated staff member, or a second manager or supervisor, in that process.
- A cognitive impairment test or an ocular scan as physical signs or evidence used to establish reasonable suspicion.
As of October 14, 2026, the CRC also says federal law or a federal contract can require an employer to follow specific testing and reasonable-suspicion procedures. That exception is important for federally regulated work.
For DOT-regulated safety-sensitive work, the federal position remains separate from New Jersey’s framework. The U.S. Department of Transportation says medical marijuana is not a valid medical explanation for a DOT positive, and marijuana use remains unacceptable for employees subject to its safety-sensitive testing rules. The federal MRO rule also says that an MRO does not decide whether an employer had proper grounds to order a test; that is an employment-policy question.
What is a WIRE, and is one required now?
As of October 14, 2026, New Jersey law calls for standards for a Workplace Impairment Recognition Expert, or WIRE, certification. The September 2022 CRC guidance says it remains interim guidance until the Commission formulates and approves those certification standards.
That guidance also says the statute does not stop employers from using established reasonable-suspicion protocols and documentation, together with other evidence such as a drug test, when deciding whether an employee violated a drug-free workplace policy. So the practical question is not simply whether someone has the WIRE title. It is whether the employer followed a documented process and what evidence it recorded for your situation.
Pending bill: S4685 and A5649
Two matching bills now before the New Jersey Legislature would carve out a set of safety-sensitive jobs from the state’s current marijuana job protections. Neither is law. Forbes reported on November 9, 2026 that Senate Bill 4685 was introduced on October 1, 2026 by Sen. Brian Stack, and that Assembly Bill 5649, with the same text, followed on October 19, 2026 under Assemblyman Larry Wainstein. The Forbes report is the source for these dates, and the S4685 bill text is where to read the wording itself.
Under the bills, covered workers could be barred from using recreational cannabis at all, including on their own time. Employers could also refuse to hire, discipline, or fire them. A positive test for cannabinoid metabolites would be enough on its own, with no proof of impairment on the job. Forbes lists the covered jobs as certain full-time law enforcement officers, paid firefighters, EMTs, paramedics, certain rescue personnel, paid 9-1-1 dispatchers, commercial drivers (CDL holders employed to operate a commercial motor vehicle), and operators of qualifying machinery weighing at least 5,000 pounds. If enacted, the bills would take effect immediately. No hearing date or vote had been reported as of November 9, 2026. Forbes also points out that THC and its metabolites can remain detectable after the effects wear off, so a positive result may reflect earlier use rather than impairment at work.
Current protections stay in force while the bills are pending. Forbes says the 2021 law, CREAMMA, generally bars firing or penalizing someone for lawful off-duty use, and that a positive test by itself generally is not enough for an adverse decision. The NJ-CRC workplace guidance, issued September 9, 2022, remains the reference. It treats a metabolite test alone as insufficient for adverse action and recommends recording observable signs of impairment. Forbes also says federal DOT rules keep commercial drivers barred from marijuana no matter what state law says. For the Jake Honig Act, which protects registered medical cannabis patients, Forbes notes that S4685 covers recreational use and does not explicitly describe how it would work alongside those protections.
If your job is on that list, ask HR or your union representative how any change would apply to your role.
What should you do after a New Jersey cannabis test?
Start by asking HR for the written drug-testing policy, the reason the test was ordered, and any documentation tied to your case. Keep copies of notices, test paperwork, job-offer communications, and the dates of any conversations. If you are represented, contact your union representative promptly.
If the result is being reviewed through a federal testing program, ask how the Medical Review Officer process applies to your result. If your job involves a federal contract, DOT rules, or another safety-sensitive requirement, ask which rule the employer says applies.
| Question to ask | Why it helps |
|---|---|
| What policy applies to my role? | It identifies the employer rule being used. |
| Why was this test ordered? | New Jersey guidance distinguishes reasonable suspicion, random testing, accidents, and other settings. |
| What observations were documented? | The CRC guidance gives weight to documented physical signs or other impairment evidence alongside a test. |
| Does a federal rule or contract apply? | Federal requirements may affect the workplace process. |
As of October 14, 2026, the CRC directs questions about an employer’s testing policy to HR and/or a lawyer specializing in employment law. This is general information, not legal advice; deadlines can be short, so talk to HR, a union representative, or an employment lawyer quickly.
By HealthDataConsortium.org Research Team
